The Code of Conduct expresses the Group’s commitment to operate not only in accordance with the laws and regulations currently in force but also with certain principles and rules of conduct of an ethical nature
The application of the following principles is guaranteed by the existence of procedures within the Group aimed at ensuring that its employees, internal bodies and third parties acting on its behalf, operate effectively in accordance with ethical principles.
This version of the Code has been approved by the Board of Directors of Chiesi Farmaceutici S.p.A., in 2021. This constitutes an official Group document and as such is binding upon all the bodies, employees, consultants, collaborators, agents and, at a more general level all third parties acting on behalf of the Group.
In order to uphold the high legal and moral standards of the Group, Chiesi also adopted an Anti-Bribery Policy in 2015. The purpose of this policy is to provide anyone acting on behalf of or in the interests of Chiesi with a series of general principles on how to recognise and deal with situations involving corruption and how to comply with related regulations.
Code of Conduct
Anti-Bribery Policy 2023
As a member of EFPIA (European Federation of Pharmaceutical Industries and Associations) we are fostering the transparency on the interaction between the pharmaceutical industry and health care professionals & organisations according EFPIA, as well as all national legal regulations, as we are convinced to be independent partners with the same goal: cooperation and exchange of knowledge, as well as research and development without unlawful interference or influence.
Disclosure DATA for the period since 1st of January 2023 to 31st December 2023
Disclosure DATA for the period since 1st of January 2022 to 31st December 2022
Disclosure DATA for the period since 1st of January 2021 to 31st December 2021
Disclosure DATA for the period since 1st of Januray 2020 to 31st December 2020
Disclosure DATA for the period since 1st of January 2019 to 31st December 2019
Disclosure DATA for the period since 1st of January 2018 to 31st December 2018
Disclosure DATA for the period since 1st of January 2017 to 31st December 2017
Disclosure DATA for the period since 1st of January 2016 to 31st December 2016
Disclosure DATA for the period since 2015.
INDIVIDUAL DISCLOSURE:
AGGREGATE DISCLOSURE:
For more questions on the EFPIA transparency codes or concerning a disclaimer or revocation of your consent to the individual disclosure, do not hesitate to contact us directly.
Support provided by Chiesi Slovakia to patient organizations in 2023